美国FDA批准药物非活性成分数据库
Inactive Ingredient Search for Approved Drug Products
非活性成分名称 给药途径 剂型 CAS登记号 物质唯一标识(UNII) 每单位剂量最大使用量 每日最大暴露量(MDE) 辅料数据
SODIUM ACETATE INTRALESIONAL INJECTION 6131904 4550K0SC9B ADJ PH 辅料数据
SODIUM ACETATE INTRAMUSCULAR INJECTION 6131904 4550K0SC9B 19 mg 辅料数据
SODIUM ACETATE INTRAOCULAR SOLUTION 6131904 4550K0SC9B 195 mg 辅料数据
SODIUM ACETATE INTRASYNOVIAL INJECTION 6131904 4550K0SC9B ADJ PH 辅料数据
SODIUM ACETATE INTRAVENOUS INJECTION 6131904 4550K0SC9B 4239 mg 辅料数据
SODIUM ACETATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 6131904 4550K0SC9B 141 mg 辅料数据
SODIUM ACETATE INTRAVENOUS INJECTION, SOLUTION 6131904 4550K0SC9B 328 mg 辅料数据
SODIUM ACETATE INTRAVENOUS LIQUID 6131904 4550K0SC9B 0.2 %w/v 辅料数据
SODIUM ACETATE INTRAVENOUS SOLUTION 6131904 4550K0SC9B 20 mg 辅料数据
SODIUM ACETATE INTRAVITREAL INJECTION, SUSPENSION 6131904 4550K0SC9B 0.39 %w/v 辅料数据
SODIUM ACETATE OPHTHALMIC EMULSION 6131904 4550K0SC9B 0.08 %w/v 辅料数据
SODIUM ACETATE OPHTHALMIC SOLUTION 6131904 4550K0SC9B 2 mg 辅料数据
SODIUM ACETATE OPHTHALMIC SOLUTION/ DROPS 6131904 4550K0SC9B 1.24 %w/v 辅料数据
SODIUM ACETATE ORAL POWDER, FOR SOLUTION 6131904 4550K0SC9B 0.1 mg 辅料数据
SODIUM ACETATE ORAL SOLUTION 6131904 4550K0SC9B 44 mg 辅料数据
SODIUM ACETATE ORAL SYRUP 6131904 4550K0SC9B 43 mg 辅料数据
SODIUM ACETATE PARENTERAL INJECTION, POWDER, FOR SOLUTION 6131904 4550K0SC9B 12.5 mg 辅料数据
SODIUM ACETATE PARENTERAL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 6131904 4550K0SC9B 250 mg 辅料数据
SODIUM ACETATE SOFT TISSUE INJECTION 6131904 4550K0SC9B ADJ PH 辅料数据
SODIUM ACETATE SUBCUTANEOUS INJECTION 6131904 4550K0SC9B 19 mg 辅料数据

数据库说明:

©2006-2026 DrugFuture->Inactive Ingredient Search for Approved Drug Products